Archive for October, 2008

Benfotiamine prevents diabetic side effects

Benfotiamine a new approach to preventing diabetic retinopathy

Benfotiamine delays formation of advanced glycosylation end-products

Benfotiamine effectiveness in diabetic neuropathy

Benfotiamine efficacy in diabetic polyneuropathy

Benfotiamine efficacy in patients diabetic neuropathy

Benfotiamine treatment of diabetic polyneuropathy

Benfotiamine is indicated in end-stage renal disease

Benfotiamine may prevent diabetic complications

Benfotiamine inhibits formation of advanced glycation end products

Benfotiamine blocks formation of advanced glycation end products

Benfotiamine blocks damage by hyperglycemia

Benfotiamine bioavailability

Benfotiamine counteracts glucose toxicity